An exosome-based liquid biopsy predicts depth of response and survival outcomes to cetuximab and panitumumab in metastatic colorectal cancer: The EXONERATE Study.

待确认 20 由森郎发布于 2025/9/15 23:04:01

DOI:10.1158/1078-0432.ccr-24-1934
作者：Caiming Xu, Alessandro Mannucci, Francis Esposito, Helena Oliveres, Vicente Alonso Ordu?a, Alfonso Yubero, Carlos Fernández-Martos, Antonieta Salud, Javier Gallego, Marta Martin-Richard, Julen Ferná
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：PURPOSE EXONERATE (EXOsome and cell-free micro-RNAs of anti-EGFR ResistAnce) was an open-label, biomarker interventional study designed to develop, test, and validate a liquid biopsy predict

应助信息

等待求助人确认

求助人未确认前，本求助不能再次应助。36小时后系统将自动确认应助成功。本求助将自动关闭。

12小时前

biofresh

6cdb80a4924611f09c3634735aa3bc31.pdf

12小时前

Book学术机器人

2025/9/15 23:04:01 未找到该文献，机器人已退出，请等待人工下载

2025/9/15 23:04:01 Book学术AI机器人收到请求，开始寻找文献

2025/9/15 23:04:01 已向机器人发送请求

12小时前

森郎发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:WileyTrans-repression of NFκB pathway mediated by PPARγ improves vascular endothelium insulin resistance